Literature DB >> 17084949

Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children.

Christiane Heeg1, Carmen Franken, Mark van der Linden, Adnan Al-Lahham, Ralf René Reinert.   

Abstract

Pneumococcal surface protein A (PspA) is a possible candidate for the development of a pneumococcal vaccine that has the potential to offer a broad range of protection. PspA genes of pneumococcal meningitis isolates (n=40) isolated as part of an ongoing population-based nation-wide surveillance program on invasive pneumococcal disease in children in Germany were analyzed to expand our knowledge on the distribution of PspA families of this important vaccine candidate in Germany. The serotype distribution of the strains was as follows: serotype 4 (n=3), 6B (5), 9V (2), 14 (8), 18C (6), 19F (5), 23F (6), and 7F (5). The pspA genes of these strains could be assigned to 2 families containing 20 pneumococcal strains each. Family I could be subdivided into 2 clades with 17 strains in clade 1 and 3 strains in clade 2, and family II could be subdivided into 3 subgroups (clades 3-5) containing 16, 3, and 1 strain, respectively. Pneumococcal serotypes were distributed evenly over all clades and families. Interestingly, the distribution of the PspA gene families in Germany was seen to differ slightly that found in other countries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17084949     DOI: 10.1016/j.vaccine.2006.09.061

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Diversity of pneumococcal surface protein A (PspA) and relation to sequence typing in Streptococcus pneumoniae causing invasive disease in Chinese children.

Authors:  J Qian; K Yao; L Xue; G Xie; Y Zheng; C Wang; Y Shang; H Wang; L Wan; L Liu; C Li; W Ji; Y Wang; P Xu; S Yu; Y-W Tang; Y Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-06-04       Impact factor: 3.267

2.  Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection.

Authors:  J Cao; D Li; Y Gong; N Yin; T Chen; C K Wong; W Xu; J Luo; X Zhang; C W K Lam; Y Yin
Journal:  Clin Exp Immunol       Date:  2009-02-11       Impact factor: 4.330

3.  PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae.

Authors:  Wei Xin; Yuhua Li; Hua Mo; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2009-08-17       Impact factor: 3.441

4.  Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers.

Authors:  Merit M Melin; Susan K Hollingshead; David E Briles; William P Hanage; Mika Lahdenkari; Tarja Kaijalainen; Terhi M Kilpi; Helena M Käyhty
Journal:  Clin Vaccine Immunol       Date:  2008-08-27

5.  Genetic diversity of pneumococcal surface protein A in invasive pneumococcal isolates from Korean children, 1991-2016.

Authors:  Ki Wook Yun; Eun Hwa Choi; Hoan Jong Lee
Journal:  PLoS One       Date:  2017-11-13       Impact factor: 3.240

Review 6.  A Jack of All Trades: The Role of Pneumococcal Surface Protein A in the Pathogenesis of Streptococcus pneumoniae.

Authors:  Jessica R Lane; Muralidhar Tata; David E Briles; Carlos J Orihuela
Journal:  Front Cell Infect Microbiol       Date:  2022-02-02       Impact factor: 6.073

7.  PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in Japan.

Authors:  Muneki Hotomi; Akihisa Togawa; Masamitsu Kono; Yorihiko Ikeda; Shin Takei; Susan K Hollingshead; David E Briles; Kenji Suzuki; Noboru Yamanaka
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

8.  Diversity of pneumococcal surface protein A (PspA) among prevalent clones in Spain.

Authors:  Dora Rolo; Carmen Ardanuy; Ana Fleites; Rogelio Martín; Josefina Liñares
Journal:  BMC Microbiol       Date:  2009-05-06       Impact factor: 3.605

9.  Proteomic and bioinformatic pipeline to screen the ligands of S. pneumoniae interacting with human brain microvascular endothelial cells.

Authors:  Irene Jiménez-Munguía; Lucia Pulzova; Evelina Kanova; Zuzana Tomeckova; Petra Majerova; Katarina Bhide; Lubos Comor; Ivana Sirochmanova; Andrej Kovac; Mangesh Bhide
Journal:  Sci Rep       Date:  2018-03-27       Impact factor: 4.379

10.  The Modified Surface Killing Assay Distinguishes between Protective and Nonprotective Antibodies to PspA.

Authors:  Kristopher R Genschmer; Cintia F M Vadesilho; Larry S McDaniel; Sang-Sang Park; Yvette Hale; Eliane N Miyaji; David E Briles
Journal:  mSphere       Date:  2019-12-11       Impact factor: 4.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.